1. Home
  2. BLLN vs TFSL Comparison

BLLN vs TFSL Comparison

Compare BLLN & TFSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

HOLD

Current Price

$104.82

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Logo TFS Financial Corporation

TFSL

TFS Financial Corporation

HOLD

Current Price

$16.90

Market Cap

4.8B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLLN
TFSL
Founded
2016
1938
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
4.8B
IPO Year
2025
2006

Fundamental Metrics

Financial Performance
Metric
BLLN
TFSL
Price
$104.82
$16.90
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$126.71
N/A
AVG Volume (30 Days)
501.7K
657.4K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
7.68%
EPS Growth
103.40
14.29
EPS
0.48
0.27
Revenue
$305,112,000.00
N/A
Revenue This Year
$46.29
$9.16
Revenue Next Year
$30.14
$5.22
P/E Ratio
$220.69
$62.65
Revenue Growth
99.97
N/A
52 Week Low
$61.96
$12.54
52 Week High
$150.44
$19.49

Technical Indicators

Market Signals
Indicator
BLLN
TFSL
Relative Strength Index (RSI) 53.45 37.63
Support Level $79.07 $16.11
Resistance Level $108.50 $17.00
Average True Range (ATR) 5.08 0.30
MACD 1.86 -0.04
Stochastic Oscillator 64.44 31.82

Price Performance

Historical Comparison
BLLN
TFSL

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

About TFSL TFS Financial Corporation

TFS Financial Corp is the holding company for the Third Federal Savings and Loan Association of Cleveland. The company's ownership in the savings and loan association is its primary business activity. The association's principal business consists of originating and servicing residential real estate mortgage loans and attracting retail savings deposits. It does so by offering products with competitive rates and yields. The company also operates Third Capital, a wholly owned subsidiary that serves as a holding company or as an investor in vehicles such as private equity funds. Third Capital has interests in lease transactions of commercial buildings, title agencies providing escrow and settlement services, and reinsurance of private mortgage insurance on residential loans.

Share on Social Networks: